Evidence map›Paper›PMID 32685161›Full record

ReviewArrhythmia & electrophysiology review2020

Ivabradine and AF: Coincidence, Correlation or a New Treatment?

Mahmoud Abdelnabi, Ashraf Ahmed, Abdallah Almaghraby, Yehia Saleh, Haitham Badran

Registry-linked trialOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Arrhythmia & electrophysiology review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05168189 (Ivabradine and Its Role in the Development of Atrial Fibrillation in Patients With Chronic Coronary Syndrome), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05168189 unknown statusnot on this mapstarted 2022, after this paper: background citation

Ivabradine and Its Role in the Development of Atrial Fibrillation in Patients With Chronic Coronary Syndrome

TypeobservationalSponsorAssiut UniversityRan2022 to 2024Enrolled180ConditionsAF - Atrial FibrillationArmsIvabradine, transthoracic echo, 24 hours holter
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mahmoud AbdelnabiCardiology and Angiology Unit, Department of Clinical and Experimental Internal Medicine, Medical Research Institute, University of Alexandria, Egypt.
Ashraf AhmedDepartment of Cardiology, Faculty of Medicine, University of Alexandria, Egypt.
Abdallah AlmaghrabyDepartment of Cardiology, Faculty of Medicine, University of Alexandria, Egypt.
Yehia SalehDepartment of Cardiology, Faculty of Medicine, University of Alexandria, Egypt.
Haitham BadranDepartment of Cardiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Alexandria University · EGAin Shams University · EGMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ivabradine is a heart rate-lowering agent that inhibits pacemaker funny current (I

Indexed as

acute coronary syndromesAFanginaheart failureheart rateIf channelsIf currentIvabradine

Identifiers

PMID32685161
PMCPMC7358942
OpenAlexW3008145167

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.